Syndax Pharmaceuticals Balance Sheet (2015-2026)

Reported Financials

Syndax Pharmaceuticals Quarterly Balance Sheet

Periods 46 quarters

Latest Jun 2026

Syndax Pharmaceuticals reported total assets of $703.65M and total liabilities of $688.55M for the quarter ended Jun 2026, up 18.0% year over year. This balance sheet covers 46 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	71.55M	222.08M	188.89M	120.35M	71.49M	74.36M	57.52M	97.28M	94.55M	295.39M	114.61M	105.40M	133.02M	154.08M	153.99M	108.64M	116.81M	134.93M	130.89M	336.48M
Short-term InvestmentsInvestments (Current)	158.28M	217.97M	209.16M	246.55M	266.46M	401.45M	374.88M	301.53M	269.01M	275.30M	319.96M	319.70M	256.59M	418.80M	358.20M	346.60M	319.17M	259.14M	221.17M	211.38M
Cash & Current Investments	229.83M	440.05M	398.05M	366.91M	337.95M	475.80M	432.39M	398.80M	363.56M	570.70M	434.58M	425.10M	389.61M	572.88M	512.20M	455.23M	435.98M	394.07M	352.06M	547.86M
Receivables - NetNet Receivables														7.60M	15.72M	19.45M	25.40M	38.00M	38.12M	45.07M
Receivables - OtherOther Receivables				13.10M	4.54M	3.47M	1.39M		3.41M		4.00M	3.50M	3.50M	3.63M	10.30M	33.20M	20.90M	28.10M	24.70M	26.40M
Receivables														11.24M	26.02M	52.65M	46.30M	66.10M	62.82M	71.47M
Raw Materials															1.74M	14.18M	21.40M	29.03M	30.70M	29.20M
Work In Process														0.33M	0.57M	1.27M	1.38M	2.11M	2.87M	2.43M
Finished Goods														0.04M	2.35M	2.25M	2.22M	1.61M	1.38M	1.53M
Inventory														0.37M	4.66M	17.70M	25.00M	32.75M	34.95M	33.16M
Prepaid Assets	8.42M	1.45M	9.03M	2.39M	2.27M	1.92M	1.91M	3.06M	3.75M	3.29M	4.67M	4.21M	4.91M	8.54M	8.46M	9.88M	9.52M	13.50M	16.10M	17.48M
Current Assets	238.25M	448.40M	420.06M	392.29M	357.63M	489.79M	441.51M	409.08M	380.97M	580.88M	453.90M	446.06M	414.81M	603.06M	548.75M	531.68M	529.83M	528.08M	471.18M	675.04M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	0.16M	0.28M	0.27M	0.26M	0.02M	0.02M	0.02M	0.01M	0.01M	0.01M	0.01M	0.00M					0.13M	0.18M	0.18M	0.21M
Long-Term Investments				12.12M		5.47M	16.56M	19.48M	15.71M	29.83M	87.42M	29.52M	10.03M	119.52M	89.94M	62.63M	20.15M			27.22M
Other Non-Current Assets	0.12M	0.12M	1.03M	0.99M	0.88M	0.81M	0.69M	0.58M	0.59M	0.46M	0.25M	0.22M	0.22M	0.22M	0.22M	0.22M	0.22M	0.10M	0.10M	0.10M
Non-Current Assets	1.25M	1.26M	2.17M	14.15M	2.06M	7.45M	18.32M	22.26M	18.25M	32.00M	89.13M	30.89M	11.00M	121.76M	91.96M	64.47M	21.96M	1.62M	1.49M	28.61M
Assets	239.50M	449.66M	422.22M	406.44M	359.69M	497.24M	459.83M	431.34M	399.22M	612.88M	543.03M	476.95M	425.81M	724.82M	640.71M	596.15M	551.79M	529.71M	472.67M	703.65M
Liabilities
Current Liabilities
Accounts Payables	5.12M	5.67M	8.23M	6.44M	7.12M	4.35M	8.06M	10.98M	6.05M	9.96M	8.81M	11.57M	4.90M	11.63M	10.05M	17.35M	13.83M	16.58M	10.84M	4.87M
Payables	5.12M	5.67M	8.23M	6.44M	7.12M	4.35M	8.06M	10.98M	6.05M	9.96M	8.81M	11.57M	4.90M	11.63M	10.05M	17.35M	13.83M	16.58M	10.84M	4.87M
Accumulated Expenses	13.73M	14.46M	18.42M	16.97M	13.21M	24.28M	15.21M	17.73M	32.12M	39.86M	33.40M	26.81M	48.12M	60.10M	55.98M	71.07M	77.11M	103.06M	74.84M	94.30M
Other Accumulated Expenses	0.19M	1.70M	1.89M	3.17M	3.19M	0.60M	0.70M	0.53M	0.77M	0.89M	1.08M	0.22M	0.21M	0.42M	0.58M	0.62M	0.59M	0.72M	1.27M	1.55M
Short term Debt	9.49M		3.57M	7.21M										12.12M
Current Deferred Revenue
Total Current Liabilities	28.71M	20.68M	30.55M	30.93M	20.80M	29.07M	23.72M	30.17M	39.17M	58.10M	50.80M	42.47M	59.38M	103.55M	94.55M	112.99M	114.19M	120.12M	86.17M	99.68M
Non-Current Liabilities
Capital Leases				0.01M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.01M	0.00M	0.00M	1.58M	1.45M	1.32M	1.19M	1.05M	0.91M	0.76M
Non-Current Debt	10.99M	19.89M	16.48M	12.99M										331.56M	329.64M	324.41M	320.99M	343.91M	343.96M	344.03M
Convertible Debt																				244.09M
Non-Current Deffered Revenue
Preferred Stock Liabilities
Operating Leases	0.80M	0.71M	0.64M	0.57M	0.77M	0.71M	0.59M	1.11M	0.85M	0.58M	0.33M	0.13M		1.58M
Other Non-Current Liabilities
Total Non-Current Liabilities	11.79M	20.61M	17.12M	13.57M	0.78M	0.72M	0.60M	1.13M	0.86M	0.59M	0.33M	0.14M	0.00M	333.14M	331.10M	325.74M	322.18M	344.96M	344.87M	588.88M
Total Liabilities	40.50M	41.29M	47.67M	44.50M	21.59M	29.79M	24.32M	31.30M	40.04M	58.68M	51.14M	42.61M	59.38M	436.69M	425.65M	438.73M	436.36M	465.08M	431.05M	688.55M
Shareholder's Equity
Total Debt	20.48M	19.89M	20.05M	20.21M										343.68M	329.64M	324.41M	320.99M	343.91M	343.96M	344.03M
Common Equity	199.00M	408.37M	374.55M	361.94M	338.10M	467.45M	435.50M	400.04M	359.19M	554.20M	491.89M	434.34M	366.43M	288.12M	215.06M	157.42M	115.43M	64.63M	41.62M	15.10M
Liabilities and Shareholders Equity	239.50M	449.66M	422.22M	406.44M	359.69M	497.24M	459.83M	431.34M	399.22M	612.88M	543.03M	476.95M	425.81M	724.82M	640.71M	596.15M	551.79M	529.71M	472.67M	703.65M
Retained Earnings	-639.90M	-543.70M	-580.87M	-618.44M	-653.85M	-693.04M	-734.17M	-778.78M	-829.93M	-902.40M	-974.80M	-1042.86M	-1126.99M	-1221.16M	-1306.00M	-1377.85M	-1438.57M	-1506.58M	-1549.25M	-1598.62M

Syndax Pharmaceuticals Balance Sheet API

Pull Syndax Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SNDX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "SNDX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=SNDX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Syndax Pharmaceuticals SNDX Balance Sheet (2015-2026)

Syndax Pharmaceuticals Quarterly Balance Sheet

Syndax Pharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password